Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/1385
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorBRUFFAERTS, Ronny-
dc.contributor.authorVILAGUT, Gemma-
dc.contributor.authorDEMYTTENAERE, Koen-
dc.contributor.authorALONSO, Jordi-
dc.contributor.authorALHAMZAWI, Ali-
dc.contributor.authorANDRADE, Laura Helena-
dc.contributor.authorBENJET, Corina-
dc.contributor.authorBROMET, Evelyn-
dc.contributor.authorBUNTING, Brendan-
dc.contributor.authorGIROLAMO, Giovanni de-
dc.contributor.authorFLORESCU, Silvia-
dc.contributor.authorGUREJE, Oye-
dc.contributor.authorHARO, Josep Maria-
dc.contributor.authorHE, Yanling-
dc.contributor.authorHINKOV, Hristo-
dc.contributor.authorHU, Chiyi-
dc.contributor.authorKARAM, Elie G.-
dc.contributor.authorLEPINE, Jean-Pierre-
dc.contributor.authorLEVINSON, Daphna-
dc.contributor.authorMATSCHINGER, Herbert-
dc.contributor.authorNAKANE, Yoshibumi-
dc.contributor.authorORMEL, Johan-
dc.contributor.authorPOSADA-VILLA, Jose-
dc.contributor.authorSCOTT, Kate M.-
dc.contributor.authorVARGHESE, Matthew-
dc.contributor.authorWILLIAMS, David R.-
dc.contributor.authorXAVIER, Miguel-
dc.contributor.authorKESSLER, Ronald C.-
dc.date.accessioned2013-07-30T17:21:52Z-
dc.date.available2013-07-30T17:21:52Z-
dc.date.issued2012-
dc.identifier.citationBRITISH JOURNAL OF PSYCHIATRY, v.200, n.6, p.454-461, 2012-
dc.identifier.issn0007-1250-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/1385-
dc.description.abstractBackground Mental and physical disorders are associated with total disability, but their effects on days with partial disability (i.e. the ability to perform some, but not full-role, functioning in daily life) are not well understood. Aims To estimate individual (i.e. the consequences for an individual with a disorder) and societal effects (i.e. the avoidable partial disability in the society due to disorders) of mental and physical disorders on days with partial disability around the world. Method Respondents from 26 nationally representative samples (n=61 259, age 18+) were interviewed regarding mental and physical disorders, and day-to-day functioning. The Composite International Diagnostic Interview, version 3.0 (CIDI 3.0) was used to assess mental disorders; partial disability (expressed in full day equivalents) was assessed with the World Health Organization Disability Assessment Schedule in the CIDI 3.0. Results Respondents with disorders reported about 1.58 additional disability days per month compared with respondents without disorders. At the individual level, mental disorders (especially post-traumatic stress disorder, depression and bipolar disorder) yielded a higher number of days with disability than physical disorders. At the societal level, the population attributable risk proportion due to physical and mental disorders was 49% and 15% respectively. Conclusions Mental and physical disorders have a considerable impact on partial disability, at both the individual and at the societal level. Physical disorders yielded higher effects on partial disability than mental disorders.-
dc.description.sponsorshipBristol-Myers Squibb-
dc.description.sponsorshipEli Lilly Company-
dc.description.sponsorshipGlaxoSmithKline-
dc.description.sponsorshipJohnson & Johnson Pharmaceuticals-
dc.description.sponsorshipOrtho-McNeil Pharmaceutical, Inc.-
dc.description.sponsorshipPfizer-
dc.description.sponsorshipSanofi-Aventis-
dc.description.sponsorshipNational Institute of Mental Health (NIH-NIMH) [R01MH070884]-
dc.description.sponsorshipMental Health Burden Study [HHSN271200700030C]-
dc.description.sponsorshipJohn D. and Catherine T. MacArthur Foundation-
dc.description.sponsorshipPfizer Foundation-
dc.description.sponsorshipUS Public Health Service [R13-MH066849, R01-MH069864, R01 DA016558]-
dc.description.sponsorshipFogarty International Center (NIH-FIRCA) [R03-TW006481]-
dc.description.sponsorshipPan American Health Organization (PAHO)-
dc.description.sponsorshipEli Lilly & Company Foundation-
dc.description.sponsorshipOrtho-McNeil Pharmaceutical-
dc.description.sponsorshipShire-
dc.description.sponsorshipState of Sao Paulo Research Foundation (FAPESP) [03/00204-3]-
dc.description.sponsorshipMinistry of Health-
dc.description.sponsorshipNational Center for Public Health Protection-
dc.description.sponsorshipShenzhen Bureau of Health-
dc.description.sponsorshipShenzhen Bureau of Science, Technology, and Information-
dc.description.sponsorshipMinistry of Social Protection-
dc.description.sponsorshipEuropean Commission [QLG5-1999-01042, 2004123]-
dc.description.sponsorshipPiedmont Region (Italy)-
dc.description.sponsorshipFondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain [FIS 00/0028]-
dc.description.sponsorshipMinisterio de Ciencia y Tecnologia, Spain [SAF 2000-158-CE]-
dc.description.sponsorshipDepartament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III [CB06/02/0046, RD06/0011]-
dc.description.sponsorshipGovernment of India-
dc.description.sponsorshipWHO-
dc.description.sponsorshipJapanese and European Funds through United Nations Development Group Iraq Trust Fund (UNDG ITF)-
dc.description.sponsorshipIsrael National Institute for Health Policy and Health Services Research-
dc.description.sponsorshipNational Insurance Institute of Israel-
dc.description.sponsorshipGrant for Research on Psychiatric and Neurological Diseases and Mental Health [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]-
dc.description.sponsorshipJapan Ministry of Health, Labour and Welfare-
dc.description.sponsorshipLebanese Ministry of Public Health-
dc.description.sponsorshipWHO (Lebanon)-
dc.description.sponsorshipFogarty International (NIH_FIRCA)-
dc.description.sponsorshipJanssen-Cilag-
dc.description.sponsorshipEli Lilly-
dc.description.sponsorshipRoche-
dc.description.sponsorshipNovartis-
dc.description.sponsorshipNational Institute of Psychiatry Ramon de la Fuente (INPRFMDIES-WHO) [4280]-
dc.description.sponsorshipNational Council on Science and Technology [CONACyT-G30544- H]-
dc.description.sponsorshipNew Zealand Ministry of Health-
dc.description.sponsorshipAlcohol Advisory Council-
dc.description.sponsorshipHealth Research Council-
dc.description.sponsorshipWHO (Geneva)-
dc.description.sponsorshipWHO (Nigeria)-
dc.description.sponsorshipFederal Ministry of Health, Abuja, Nigeria-
dc.description.sponsorshipHealth & Social Care Research & Development Division of the Public Health Agency-
dc.description.sponsorshipChampalimaud Foundation-
dc.description.sponsorshipGulbenkian Foundation-
dc.description.sponsorshipFoundation for Science and Technology (FCT)-
dc.description.sponsorshipMinistry of Public Health-
dc.description.sponsorshipNIH/US NIMH [R01-MH059575, RO1-MH61905]-
dc.description.sponsorshipNational Institute of Drug Abuse (NIH-NIDA)-
dc.description.sponsorshipSouth African Department of Health-
dc.description.sponsorshipUniversity of Michigan-
dc.description.sponsorshipNational Institute of Mental Health (NIH-NIMH) [U01-MH60220]-
dc.description.sponsorshipRobert Wood Johnson Foundation (RWJF) [044708]-
dc.language.isoeng-
dc.publisherROYAL COLLEGE OF PSYCHIATRISTS-
dc.relation.ispartofBritish Journal of Psychiatry-
dc.rightsrestrictedAccess-
dc.subject.otherdiagnostic interview cidi-
dc.subject.otherpsychiatric-disorders-
dc.subject.otherhealth-organization-
dc.subject.otherpatients pain-
dc.subject.othercomorbidity-
dc.subject.otherimpact-
dc.subject.otherpresenteeism-
dc.subject.otherinformation-
dc.subject.otherworkplace-
dc.subject.otherillness-
dc.titleRole of common mental and physical disorders in partial disability around the world-
dc.typearticle-
dc.rights.holderCopyright ROYAL COLLEGE OF PSYCHIATRISTS-
dc.identifier.doi10.1192/bjp.bp.111.097519-
dc.identifier.pmid22539779-
dc.subject.wosPsychiatry-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalBRUFFAERTS, Ronny:Katholieke Univ Leuven, Univ Psychiat Ctr, Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium-
hcfmusp.author.externalVILAGUT, Gemma:Hosp Mar, IMIM, Hlth Serv Res Unit, Barcelona, Spain; CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain-
hcfmusp.author.externalDEMYTTENAERE, Koen:Katholieke Univ Leuven, Univ Psychiat Ctr, Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium-
hcfmusp.author.externalALONSO, Jordi:Hosp Mar, IMIM, Hlth Serv Res Unit, Barcelona, Spain; CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain-
hcfmusp.author.externalALHAMZAWI, Ali:Al Qadisia Univ, Coll Med, Al Diwaniyah, Iraq-
hcfmusp.author.externalBENJET, Corina:Natl Inst Psychiat, Mexico City, DF, Mexico-
hcfmusp.author.externalBROMET, Evelyn:SUNY Stony Brook, Stony Brook, NY 11794 USA-
hcfmusp.author.externalBUNTING, Brendan:Univ Ulster, Sch Psychol, Belfast, Antrim, North Ireland-
hcfmusp.author.externalGIROLAMO, Giovanni de:IRCCS Ctr S Giovanni di Dio Fatebenefratelli, Brescia, Italy-
hcfmusp.author.externalFLORESCU, Silvia:Scoala Natl Sanatate Publ & Perfectionare Domeniu, Bucharest, Romania-
hcfmusp.author.externalGUREJE, Oye:Univ Coll Hosp, Ibadan, Nigeria-
hcfmusp.author.externalHARO, Josep Maria:CIBERSAM, Barcelona, Spain-
hcfmusp.author.externalHE, Yanling:Shanghai Mental Hlth Ctr, Shanghai, Peoples R China-
hcfmusp.author.externalHINKOV, Hristo:Natl Ctr Publ Hlth Protect, Dept Global Mental Hlth, Sofia, Bulgaria-
hcfmusp.author.externalHU, Chiyi:Shenzhen Inst Mental Hlth, Shenzhen, Peoples R China; Shenzhen Kangning Hosp, Shenzhen, Peoples R China-
hcfmusp.author.externalKARAM, Elie G.:Balamand Univ, St George Hosp Univ Med Ctr, Fac Med, IDRAAC,MIND, Beirut, Lebanon-
hcfmusp.author.externalLEPINE, Jean-Pierre:Univ Paris Diderot & Paris Descartes Paris, Hop Lariboisiere Fernand Widal, AP HP, HDR,INSERM,U705, Paris, France-
hcfmusp.author.externalLEVINSON, Daphna:Minist Hlth, Mental Hlth Serv, Jerusalem, Israel-
hcfmusp.author.externalMATSCHINGER, Herbert:Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, Leipzig, Germany-
hcfmusp.author.externalNAKANE, Yoshibumi:Nagasaki Int Univ, Grad Sch, Div Human Sociol, Nagasaki, Japan-
hcfmusp.author.externalORMEL, Johan:Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychiat Epidemiol, NL-9700 AB Groningen, Netherlands-
hcfmusp.author.externalPOSADA-VILLA, Jose:Inst Colombiano Sistema Nervioso, Bogota, Colombia-
hcfmusp.author.externalSCOTT, Kate M.:Wellington Sch Med & Hlth Sci, Dept Psychol Med, Wellington, New Zealand-
hcfmusp.author.externalVARGHESE, Matthew:Natl Inst Mental Hlth & Neuro Sci NIMHANS, Adult Unit, Delhi, India; Natl Inst Mental Hlth & Neuro Sci NIMHANS, Geriatr Unit, Delhi, India; Natl Inst Mental Hlth & Neuro Sci NIMHANS, Family Psychiat Unit, Delhi, India-
hcfmusp.author.externalWILLIAMS, David R.:Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Dept Publ Hlth, Boston, MA 02115 USA-
hcfmusp.author.externalXAVIER, Miguel:Univ Nova Lisboa, Fac Ciencias Med, CEDOC, Dept Mental Hlth, Lisbon, Portugal-
hcfmusp.author.externalKESSLER, Ronald C.:Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA-
hcfmusp.description.beginpage454-
hcfmusp.description.endpage461-
hcfmusp.description.issue6-
hcfmusp.description.volume200-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84862001082-
hcfmusp.origem.idWOS:000305300700006-
hcfmusp.publisher.cityLONDON-
hcfmusp.publisher.countryENGLAND-
hcfmusp.relation.referenceAlonso J., 2004, ACTA PSYCHIAT SCAND, P38, DOI 10.1111/J.1600-0047.2004.00325.X-
hcfmusp.relation.referenceAlonso J., 2010, MOL PSYCHIATR, V16, P1234-
hcfmusp.relation.referenceBair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433-
hcfmusp.relation.referenceBaker MM, 2001, WHAT DO SELF REPORTE-
hcfmusp.relation.referenceBergstrom G, 2009, J OCCUP ENVIRON MED, V51, P629, DOI [10.1097/JOM.0b013e3181a8281b, 10.1097/JOM.0b913e3181a8281b]-
hcfmusp.relation.referenceBIERINGSORENSEN F, 1984, SPINE, V9, P280, DOI 10.1097/00007632-198404000-00010-
hcfmusp.relation.referenceBuist-Bouwman MA, 2005, ACTA PSYCHIAT SCAND, V111, P436, DOI 10.1111/j.1600-0447.2005.00513.x-
hcfmusp.relation.referenceCenter for Disease Control and Prevention, 2004, HLTH US 2004-
hcfmusp.relation.referenceDewa Carolyn S, 2004, Healthc Pap, V5, P12-
hcfmusp.relation.referenceDewa CS, 2000, SOC SCI MED, V51, P41, DOI 10.1016/S0277-9536(99)00431-1-
hcfmusp.relation.referenceDewa CS, 2007, PSYCHIAT SERV, V58, P652, DOI 10.1176/appi.ps.58.5.652-
hcfmusp.relation.referenceGoetzel RZ, 2004, J OCCUP ENVIRON MED, V46, P398, DOI 10.1097/01.jom.0000121151.40413.bd-
hcfmusp.relation.referenceHarkness J., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P91-
hcfmusp.relation.referenceHaro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196-
hcfmusp.relation.referenceHARRISON A, 1991, J ADV NURS, V16, P1018, DOI 10.1111/j.1365-2648.1991.tb03361.x-
hcfmusp.relation.referenceHeeringa S. G., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P14-
hcfmusp.relation.referenceHeffler S, 2002, HEALTH AFFAIR, V21, P207, DOI 10.1377/hlthaff.21.2.207-
hcfmusp.relation.referenceJamison RN, 2006, J PAIN, V7, P192, DOI 10.1016/j.jpain.2005.10.006-
hcfmusp.relation.referenceKatschnig H, 1997, QUALITY LIFE MENTAL-
hcfmusp.relation.referenceKessler RC, 2003, J OCCUP ENVIRON MED, V45, P1257, DOI 10.1097/01.jom.0000100000.70011.bb-
hcfmusp.relation.referenceKessler RC, 1997, PSYCHOL MED, V27, P861, DOI 10.1017/S0033291797004807-
hcfmusp.relation.referenceKessler RC, 2004, J OCCUP ENVIRON MED, V46, pS23, DOI 10.1097/01.jom.0000126683.75201.c5-
hcfmusp.relation.referenceKessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168-
hcfmusp.relation.referenceKnight M, 2001, J PUBLIC HEALTH MED, V23, P179, DOI 10.1093/pubmed/23.3.179-
hcfmusp.relation.referenceKriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0-
hcfmusp.relation.referenceLerner D, 2005, J OCCUP ENVIRON MED, V47, P253, DOI 10.1097/01.jom.0000150206.04540.e7-
hcfmusp.relation.referenceMerikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P1180, DOI 10.1001/archpsyc.64.10.1180-
hcfmusp.relation.referenceNational Center for Health Statistics, 1994, VITAL HLTH STAT 2, V120, P1-
hcfmusp.relation.referenceORMEL J, 1994, JAMA-J AM MED ASSOC, V272, P1741, DOI 10.1001/jama.272.22.1741-
hcfmusp.relation.referencePennell B. E., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P33-
hcfmusp.relation.referencePolder JJ, 2004, COST ILLNESS NETHERL-
hcfmusp.relation.referenceSchoenborn CA, 2003, VITAL HLTH STAT, V10, P1-
hcfmusp.relation.referenceSmit F, 2006, J MENT HEALTH POLICY, V9, P193-
hcfmusp.relation.referenceSolomon P, 2001, SCAND J CARING SCI, V15, P174, DOI 10.1046/j.1471-6712.2001.00027.x-
hcfmusp.relation.referenceStewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443-
hcfmusp.relation.referenceVon Korff M, 2008, J CLIN EPIDEMIOL, V61, P1132, DOI 10.1016/j.jclinepi.2007.12.009-
hcfmusp.relation.referenceWITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1-
hcfmusp.relation.referenceWolter KM, 1985, INTRO VARIANCE ESTIM-
hcfmusp.relation.referenceWorld Bank, 2008, DAT STAT-
hcfmusp.relation.referenceWHO, 2011, WORLD REPORT ON DISABILITY, P1-
dc.description.indexMEDLINE-
hcfmusp.remissive.sponsorshipBristol-Myers Squibb-
hcfmusp.remissive.sponsorshipEuropean Union-
hcfmusp.remissive.sponsorshipFAPESP-
hcfmusp.remissive.sponsorshipGlaxoSmithKline-
hcfmusp.remissive.sponsorshipJanssen-
hcfmusp.remissive.sponsorshipLilly-
hcfmusp.remissive.sponsorshipNIH-
hcfmusp.remissive.sponsorshipNovartis-
hcfmusp.remissive.sponsorshipPAHO-
hcfmusp.remissive.sponsorshipPfizer-
hcfmusp.remissive.sponsorshipRoche-
hcfmusp.remissive.sponsorshipSanofi-Aventis-
hcfmusp.remissive.sponsorshipWHO-
hcfmusp.remissive.sponsorshipBristol-Myers Squibb-
hcfmusp.remissive.sponsorshipEuropean Union-
hcfmusp.remissive.sponsorshipFAPESP-
hcfmusp.remissive.sponsorshipGlaxoSmithKline-
hcfmusp.remissive.sponsorshipInstituto de Salud Carlos III-
hcfmusp.remissive.sponsorshipJanssen-
hcfmusp.remissive.sponsorshipJohnson and Johnson-
hcfmusp.remissive.sponsorshipLilly-
hcfmusp.remissive.sponsorshipMacArthur Foundation-
hcfmusp.remissive.sponsorshipNIH-
hcfmusp.remissive.sponsorshipNovartis-
hcfmusp.remissive.sponsorshipPAHO-
hcfmusp.remissive.sponsorshipPfizer-
hcfmusp.remissive.sponsorshipRoche-
hcfmusp.remissive.sponsorshipSanofi-Aventis-
hcfmusp.remissive.sponsorshipWHO-
hcfmusp.remissive.sponsorshipShire-
hcfmusp.lim.ref2012-
hcfmusp.citation.scopus64-
hcfmusp.scopus.lastupdate2022-05-06-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - HC/IPq
Instituto de Psiquiatria - HC/IPq

Artigos e Materiais de Revistas Científicas - LIM/23
LIM/23 - Laboratório de Psicopatologia e Terapêutica Psiquiátrica


Files in This Item:
File Description SizeFormat 
art_ANDRADE_Role_of_common_mental_and_physical_disorders_in_2012.PDF
  Restricted Access
publishedVersion (English)358.67 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.